These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13469430)

  • 21. [A method for determination of the reducing power of urine after oral administration of PAS, as well as PAS metabolism in man].
    MEYER ZU SCHWABEDISSEN O; ZIMMERMANN J
    Klin Wochenschr; 1953 Jan; 31(3-4):87-90. PubMed ID: 13062581
    [No Abstract]   [Full Text] [Related]  

  • 22. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
    Rijk MC; van Schaik A; van Tongeren JH
    Scand J Gastroenterol; 1988 Jan; 23(1):107-12. PubMed ID: 2894070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of an inhibitory substance (p-carboxybenzol-sulfo-di-N-butylamide) on the excretion of penicillin and PAS].
    BRUCKSCHEN E
    Medizinische; 1952 Oct; 20(41):1295-8. PubMed ID: 13001794
    [No Abstract]   [Full Text] [Related]  

  • 24. [Concentration of colimycin in the blood and its excretion with urine following oral administration].
    IUDINTSEV SD; KUNRAT Ia
    Antibiotiki (Mosc); 1959; 4(3):36-9. PubMed ID: 24545334
    [No Abstract]   [Full Text] [Related]  

  • 25. DETERMINATION OF P-AMINOSALICYLIC ACID ALONE AND IN PRESENCE OF ISONIAZID.
    HAMILTON EJ; EIDUS L; LEE YS
    Clin Chim Acta; 1963 Sep; 8():763-7. PubMed ID: 14069657
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
    Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
    [No Abstract]   [Full Text] [Related]  

  • 27. Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulfasalazine, in rats.
    Pieniaszek HJ; Bates TR
    J Pharm Sci; 1979 Oct; 68(10):1323-5. PubMed ID: 41931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The absorption and excretion of para-aminobenzoic acid.
    BLOOMBERG BM
    S Afr J Med Sci; 1946 Nov; 11(2-3):51-68. PubMed ID: 20282006
    [No Abstract]   [Full Text] [Related]  

  • 29. The spectrophotometric determination of para-aminosalicylic acid and its acetyl derivative in human urine.
    CHARNEY J; KUNA M
    Am Rev Tuberc; 1951 Nov; 64(5):577-8. PubMed ID: 14885690
    [No Abstract]   [Full Text] [Related]  

  • 30. Determination of para-aminosalicylic acid blood levels.
    WILSON BJ; ARMSTRONG BW
    Am J Clin Pathol; 1949 Sep; 19(9):886-90. PubMed ID: 18137787
    [No Abstract]   [Full Text] [Related]  

  • 31. Salicylate detection on urine in PAS treatment.
    BARTHOLOMEW AT
    Am J Med Technol; 1962; 28():288-90. PubMed ID: 13969691
    [No Abstract]   [Full Text] [Related]  

  • 32. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 33. [Calcium excretion in therapy with antituberculotic drugs].
    LANYI RM
    Z Tuberk; 1952; 101(3-4):190-2. PubMed ID: 13039456
    [No Abstract]   [Full Text] [Related]  

  • 34. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
    NIELSEN E; PRAETORIUS E
    Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
    [No Abstract]   [Full Text] [Related]  

  • 35. [CHEMICAL CONTROL OF THE TREATMENT OF TUBERCULOSIS WITH PAS].
    ZIGIC M
    Tuberkuloza; 1963; 15():390-2. PubMed ID: 14102587
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the effect of various derivatives of para-aminosalicylic acid on serum levels of antimicrobially active isoniazid.
    LEVY D; HAAPANEN J; RUSSELL WF; NINIO S; NISHIO K; MIDDLEBROOK G
    Acta Tuberc Scand; 1960; 39():297-302. PubMed ID: 13761594
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphoma-like syndrome following para-aminosalicylic acid.
    Nagaratnam N; Bhuvanendran N; Jiffry AJ; Ramachandra V
    Postgrad Med J; 1982 Nov; 58(685):729-30. PubMed ID: 7170278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Absorption and excretion of drugs. XI. Separatory determination of the urinary metabolites of p-aminosalicylic acid in man].
    KAKEMI K; ARITA T; YAMASHINA H; KONISHI R
    Yakugaku Zasshi; 1962 Apr; 82():540-2. PubMed ID: 14453192
    [No Abstract]   [Full Text] [Related]  

  • 39. [EFFECT OF STREPTOMYCIN, PARA-AMINOSALICYLIC ACID AND ISONICOTINIC ACID HYDRAZIDE ON THE ABSORPTION OF GLUCOSE BY THE ISOLATED SMALL INTESTINE OF THE RAT].
    GARNUSZEWSKI Z; MAZUR M
    Gruzlica (1926); 1963 Jun; 31():635-7. PubMed ID: 14119442
    [No Abstract]   [Full Text] [Related]  

  • 40. [Distribution, resorption and excretion following repeated oral administration of conteben. II].
    HINRICHS K; POPPE H; STEYER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 221(1):6-13. PubMed ID: 13154417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.